JAK2 and colitis: The NF-κB/IL-6/Stat3 and JAK2/Stat3 pathways may be critically involved in CAC tumorigenesis, and it was found that AFE ameliorated colitis and inhibited CAC by downregulating these two inflammation-related signaling pathways.